$tr2['classname']

肺癌

$tr2['classname']

乳腺癌

$tr2['classname']

结直肠癌

$tr2['classname']

前列腺癌

$tr2['classname']

甲状腺癌

$tr2['classname']

宫颈癌

$tr2['classname']

胃癌

$tr2['classname']

肝癌

$tr2['classname']

胆囊癌

$tr2['classname']

卵巢癌

$tr2['classname']

食管癌

$tr2['classname']

胰腺癌

$tr2['classname']

膀胱癌

$tr2['classname']

淋巴瘤

$tr2['classname']

子宫内膜癌

$tr2['classname']

肾癌

$tr2['classname']

罕见肿瘤

首页 > TAG信息列表 > EGFR阳性非小细胞肺癌

肺癌|肺癌特药

ESMO丨EGFR突变非小细胞肺癌治疗专家共识(2022)

信迪利单抗|上市信息

礼来联合信达生物宣布达伯舒(信迪利单抗 )在中国获批用于经EGFR-TK

amivantamab|最新研究

治疗EGFR突变非小细胞肺癌患者,杨森双特异性抗体(amivantamab)组合